FINAL PROGRAMME
Free Communication Session + Mini Lecture 25
| HALL A9 | 08:00 - 09:30 |
| Transplantation - 3 |
| Chairs: | Anders Hartmann, Oslo, Norway |
| Francesco Paolo Schena, Bari, Italy |
| Mini Lecture | |
| Drugs and glucose metabolism in the transplant patient | |
| Francesco Paolo Schena, Bari, Italy | |
| FREE COMMUNICATIONS | |
| TO001 | |
| MONITORING OF BKV LOAD IN URINE ALLOWS IDENTIFICATION OF PATIENTS WITH THE HIGH RISK FOR BKV-ASSOCIATED NEPHROPATHY SEVERAL WEEKS PRIOR TO DEVELOPMENT OF VIREMIA: ANALYSIS OF 4128 URINE AND SERUM SAMPLES | |
| Nina Babel,1 Juliane Fendt,1 Stoyan Karaivanov,1 Lydia Stele, 1 Hans-Dieter Volk,2 Petra Reinke.1 1Dept Nephrology & Internal Intensive Care, Charite Universitaetsmedizin - Campus Virchow Clinic, Berlin, Germany; 2Inst Medical Immunology, Charite Universitaetsmedizin - Campus Mitte, Berlin, Germany | |
| TO002 | |
| CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND GRAFT LOSS IN RENAL TRANSPLANT PATIENTS | |
| Maria Jose Soler,1 Ofelia Maria Martinez-Estrada,2 Josep Maria Puig-Mari,1 Didac Marco-Feliu,2 Marisa Mir,1 Anna Oliveras,1 Senen Vilaro,2 Josep Lloveras.1 | |
| 1Nephrology Dept, Hosp del Mar, Univ Autonoma Barcelona, Barcelona, Spain; 2Cellular Biology Dept, Fac Biologia, Univ Barcelona, Barcelona, Spain | |
| TO003 | |
| SIROLIMUS VERSUS MYCOPHENOLATE MOFETIL IN TACROLIMUS BASED PRIMARY SIMULTANEOUS PANCREAS- KIDNEY (SPK) TRANSPLANTATION: 1 YEAR RESULTS OF A MULTICENTRE TRIAL | |
| Patrick Peeters, Jacques Malaise, Johann Pratschke, Frantisek Saudek, Raimund Margreiter, Helmut Arbogast, Luiz Fernandez-Cruz, Przemylaw Pisarski, Richard Viebahn, Richard Nakache, Thierry Berney, Yves Vanrenterghem, Wolf-Otto Bechstein. EuroSPK Study Group, Brussels, Belgium | |
| TO004 | |
| GENE EXPRESSION DIFFERENCES BETWEEN LIVING AND DECEASED DONOR KIDNEYS IN HUMAN TRANSPLANTATION | |
| Maarten Naesens,1,2 Li Li,1 Li Hua Ying,1 Oscar Salvatierra, 1 Atul Butte,1 Minnie Sarwal.1 1Stanford Univ Medical School, CA, USA; 2Univ Hosps Leuven, Leuven, Belgium | |
| TO005 | |
| MYCOPHENOLATE MOFETIL VS. SIROLIMUS IN HIGH IMMUNOLOGIC RISK RENAL TRANSPLANT RECIPIENTS RECEIVING TACROLIMUS-BASED IMMUNOSUPPRESSIVE REGIMEN WITH ATG INDUCTION | |
| Magdalena Durlik,1 Olga Tronina,1 Teresa Baczkowska,1 Arkadiusz Urbanowicz,1 Marian Klinger,2 Boleslaw Rutkowski, 2 Andrzej Wiecek,2 Marek Ostrowski,2 Leszek Paczek, 2 Jacek Szmidt,2 Wojciech Rowinski.2 | |
| 1Dept Transplantation Medicine & Nephrology, Medical Univ Warsaw, Warsaw, Poland; 2Polish Study Group, Poland | |
|
|
|
|